Drawing for DAILYTAD

USPTO serial 97858289

DAILYTAD

Reviewed by CopyMark Law Group

Reg. 7525297Status 700Registered
Filing date
Status date
Registration date
Oct 1, 2024
Examiner
REEVES, APRIL ELIZABETH
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with DAILYTAD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kelly L. Williams

Kelly L. Williams QUARLES & BRADY LLP2020 K Street, NW, Suite 400WASHINGTON, DC 20006-1806United States

Goods and services

ClassDescriptionStatusFirst use
044Health counseling in the fields of erectile dysfunction, improving blood circulation and in obtaining prescription medications for treating such conditions; Internet-based health care information services in the fields of erectile dysfunction, improving blood circulation and in obtaining prescription medications for treating such conditions; Providing health information in the fields of erectile dysfunction, improving blood circulation and in obtaining prescription medications for treating such conditions; Telemedicine services in the fields of erectile dysfunction, improving blood circulation and in obtaining prescription medications for treating such conditionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 1, 2025ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Oct 1, 2024NRCSNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 1, 2024R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Aug 28, 2024CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER—
Aug 28, 2024IUAAUSE AMENDMENT ACCEPTED—
Aug 27, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 3, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 3, 2024AUPCAMENDMENT TO USE PROCESSING COMPLETE—
Aug 3, 2024IUAFUSE AMENDMENT FILED—
Aug 3, 2024EAAUTEAS AMENDMENT OF USE RECEIVED—
Aug 3, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 3, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
May 3, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Feb 6, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 6, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 6, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 28, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 28, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 28, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 24, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 24, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 24, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 20, 2023DOCKASSIGNED TO EXAMINER—
Apr 18, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 30, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance